Viewing Study NCT00278369


Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2026-02-25 @ 7:22 PM
Study NCT ID: NCT00278369
Status: COMPLETED
Last Update Posted: 2013-05-22
First Post: 2006-01-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer
Sponsor: Northwestern University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: NU 04U1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View